Marriott International president and CEO Arne Sorenson has been diagnosed with stage two pancreatic cancer, but doctors are confident treatment will end by the end of this year due to the cancer being detected early. Sorenson will continue in his role during this period.
BETHESDA, Md., May 3, 2019 -- Marriott International, Inc. (NASDAQ: MAR) today announced that President and CEO Arne Sorenson was diagnosed on Wednesday with stage 2 pancreatic cancer. Sorenson, 60, received the diagnosis from a medical team at Johns Hopkins Hospital in Baltimore after a series of tests. Sorenson will remain in his role while undergoing treatment.
In a message to Marriott International associates, Sorenson noted: "The cancer was discovered early. It does not appear to have spread and the medical team – and I – are confident that we can realistically aim for a complete cure. In the meantime, I intend to continue working at the company I love. Let me make one request, look ahead with me. We have great work underway at Marriott. I am as excited by what we can accomplish together as I have ever been."
Sorenson's treatment plan will begin next week with chemotherapy. His doctors anticipate surgery near year end 2019.
The above is a news release written by a third party. While HNN’s editorial mission is to produce unique content, it occasionally publishes timely, newsworthy news releases to complement in-house reporting efforts. All news releases are clearly marked as such. For questions and clarification, please contact Editorial Director Stephanie Ricca at firstname.lastname@example.org.